Cargando…

Potent antitumor effects of the conditioned medium of bone marrow‐derived mesenchymal stem cells via IGFBP‐4

Cell transfer therapy using mesenchymal stem cells (MSCs) has pronounced therapeutic potential, but concerns remain about immune rejection, emboli formation, and promotion of tumor progression. Because the mode of action of MSCs highly relies on their paracrine effects through secretion of bioactive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furusaka, Yuma, Inoue, Shinya, Mizoguchi, Izuru, Hasegawa, Hideaki, Katahira, Yasuhiro, Watanabe, Aruma, Sakamoto, Eri, Sekine, Ami, Miyakawa, Satomi, Umezu, Tomohiro, Owaki, Toshiyuki, Yoneto, Toshihiko, Yoshimoto, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486206/ https://www.ncbi.nlm.nih.gov/pubmed/36942841 http://dx.doi.org/10.1111/cas.15789

Ejemplares similares

A Chaperone-Like Role for EBI3 in Collaboration With Calnexin Under Inflammatory Conditions
por: Watanabe, Aruma, et al.
Publicado: (2021)

Protective effects of conditioned media of immortalized stem cells from human exfoliated deciduous teeth on pressure ulcer formation
por: Katahira, Yasuhiro, et al.
Publicado: (2023)

Induction of potent antitumor immunity by intradermal DNA injection using a novel needle‐free pyro‐drive jet injector
por: Inoue, Shinya, et al.
Publicado: (2022)

Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation
por: Sakamoto, Eri, et al.
Publicado: (2023)

A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant
por: Sonoda, Jukito, et al.
Publicado: (2023)

IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development
por: Hasegawa, Hideaki, et al.
Publicado: (2021)

Author Correction: IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development
por: Hasegawa, Hideaki, et al.
Publicado: (2021)

Prediction of Chemical Respiratory and Contact Sensitizers by OX40L Expression in Dendritic Cells Using a Novel 3D Coculture System
por: Mizoguchi, Izuru, et al.
Publicado: (2017)

Potential clinical application of interleukin-27 as an antitumor agent
por: Yoshimoto, Takayuki, et al.
Publicado: (2015)

Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
por: Xu, Mingli, et al.
Publicado: (2010)

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely
por: Ohyashiki, Junko H, et al.
Publicado: (2014)

Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family
por: Hasegawa, Hideaki, et al.
Publicado: (2016)

Case report: two cases of extremely rare primary pure squamous cell carcinoma of the breast
por: Yoneto, Toshihiko, et al.
Publicado: (2018)

Microbial Antigen-Presenting Extracellular Vesicles Derived from Genetically Modified Tumor Cells Promote Antitumor Activity of Dendritic Cells
por: Ito, Tomoko, et al.
Publicado: (2021)

Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report
por: Yoneto, Toshihiko, et al.
Publicado: (2023)

A patient with stage IIIB advanced breast cancer who is still alive 24 years after surgery: a case report and remarks on the treatment strategies
por: Yoneto, Toshihiko, et al.
Publicado: (2022)

Delayed and Synchronous Recurrence of Breast Cancer Metastases in Multiple Organs
por: Owaki, Takashi, et al.
Publicado: (2022)

Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020)

IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner
por: Chiba, Yukino, et al.
Publicado: (2013)

Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016)

A Pivotal Role for Interleukin-27 in CD8(+) T Cell Functions and Generation of Cytotoxic T Lymphocytes
por: Morishima, Noriko, et al.
Publicado: (2010)

Increased Concentrations of Insulin-Like Growth Factor Binding Protein (IGFBP)-2, IGFBP-3, and IGFBP-4 Are Associated With Fetal Mortality in Pregnant Cows
por: Mense, Kirsten, et al.
Publicado: (2018)

Local Administration of GITR Agonistic Antibody Induces a Stronger Antitumor Immunity than Systemic Delivery
por: Narumi, Kenta, et al.
Publicado: (2019)

IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer
por: Cai, Qing, et al.
Publicado: (2020)

Urinary NGAL, IGFBP-7, and TIMP-2: novel biomarkers to predict contrast medium-induced acute kidney injury in children
por: Sun, Qianliang, et al.
Publicado: (2022)

Potent antitumor activity of cepharanthine against triple-negative breast cancer spheroids compared with tetrandrine
por: Kiyomi, Anna, et al.
Publicado: (2020)

IGFBP-1 and IGFBP-2 are associated with a decreased pulse-wave velocity in young, healthy adults
por: Pettersson-Pablo, Paul, et al.
Publicado: (2021)

Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse
por: Yoshimoto, Takayuki, et al.
Publicado: (2014)

SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2
por: Masuo, Kenji, et al.
Publicado: (2021)

Regulation of IGFBP-1 in Metabolic Diseases
por: Bae, Jae-Hoon, et al.
Publicado: (2013)

Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
por: Qu, Ning, et al.
Publicado: (2013)

Benefits of Premaquick(®) Combined Detection of IL-6/Total IGFBP-1/Native IGFBP-1 to Predict Preterm Delivery
por: Pambet, Mathilde, et al.
Publicado: (2023)

Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2021)

Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer
por: SUZUKI, MAKOTO, et al.
Publicado: (2013)

IGFBP3 Colocalizes with and Regulates Hypocretin (Orexin)
por: Honda, Makoto, et al.
Publicado: (2009)

Regulation of IGFBP-2 expression during fasting
por: Kang, Hye Suk, et al.
Publicado: (2015)

Biochemical determinants of the IGFBP‐3–hyaluronan interaction
por: Dorandish, Sadaf, et al.
Publicado: (2020)

Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer
por: Liu, Qi, et al.
Publicado: (2021)

IGF-1 and IGFBP-3 in Inflammatory Cachexia
por: Martín, Ana Isabel, et al.
Publicado: (2021)

Cognition may link cortical IGFBP5 levels with motor function in older adults
por: Buchman, Aron S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0ki5orsd4npcqig2pmo63u0n8a